Johnson & Johnson JNJ reported fourth-quarter earnings of $1.88 per share on Wednesday, which beat the analyst consensus estimate of $1.87 by 0.53%. This is a 4.57% decrease over earnings of $1.97 per share from the same period last year.
The company reported quarterly sales of $20.75 billion, which missed the analyst consensus estimate of $20.78 billion by 0.14%. This is a 1.75% increase over sales of $20.394 billion the same period last year.
The company says it sees fiscal year 2020 adjusted operational EPS at $9-$9.15, and operational sales at $85.8-$86.6 billion.
Johnson & Johnson shares were trading down 1.7% at $146.70 in Wednesday's pre-market session. The stock has a 52-week high of $150.17 and a 52-week low of $125.
Related Links:
Johnson & Johnson Trades Higher On Q2 Earnings Beat
Johnson & Johnson Trades Higher On Q3 Beat-And-Raise, Despite Legal Entanglements
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
